|
Delayed
NSE India S.E.
02:53:28 2026-09-17 EDT
|
5-day change | 1st Jan Change | ||
| 2,406.70 INR | -0.14% |
|
-0.51% | +18.05% |
| 09-11 | Glenmark Pharmaceuticals Limited Proposes Dividend for the Year Ended 31 March 2026 | CI |
| 09-07 | Acucort wins trademark protection for Zeqmelit in Ukraine | FW |
Stock exchange
NSE India S.E.
GLENMARK 2,406.70 ₹
-0.14%
283M
₹
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| GLENMARK | 2,406.70INR | -0.14% | 283M ₹ | ||
Bombay S.E.
| GLENMARK | 2,408.85INR | +0.05% | 4.67M ₹ |
Quotes 5-day view: Glenmark Pharmaceuticals Limited
Delayed Quote NSE India S.E.
| 2026-09-10 | 2026-09-11 | 2026-09-15 | 2026-09-16 | 2026-09-17 | |
|---|---|---|---|---|---|
| Last | ₹2,415.00 | ₹2,419.20 | ₹2,371.70 | ₹2,410.00 | ₹2,406.70 |
| Volume | 262,107 | 346,692 | 275,789 | 677,704 | 117,724 |
| Change | -0.82% | +0.17% | -1.96% | +1.61% | -0.14% |
| Opening | ₹2,445.90 | ₹2,411.20 | ₹2,420.80 | ₹2,371.70 | ₹2,406.80 |
| High | ₹2,449.90 | ₹2,431.90 | ₹2,429.80 | ₹2,425.80 | ₹2,411.10 |
| Low | ₹2,403.10 | ₹2,384.10 | ₹2,346.60 | ₹2,306.30 | ₹2,388.40 |
Performance
| 1 day | -0.31% | ||
| 1 week | -0.51% | ||
| Current month | -3.12% | ||
| 1 month | +3.16% | ||
| 3 months | +12.45% | ||
| 6 months | +11.96% | ||
| Current year | +18.05% | ||
| 1 year | +17.64% | ||
| 3 years | +182.14% | ||
| 5 years | +363.06% | ||
| 10 years | +161.00% |
Volumes
marketsDaily volume
117,724
Estimated daily volume
309,061
Avg. Volume 20 sessions
496,969
Daily volume ratio
0.62
Avg. Volume 20 sessions INR
1,196,055,292.3
Avg. Volume 20 sessions USD
12,476,052.75
Record volume 1
89,266,590
Record volume 2
65,123,680
Record volume 3
39,631,540
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (INR)
680,103,949,716
Market Cap (USD)
7,089,437,828
Net sales (INR)
169,825,110,000
Net sales (USD)
1,770,265,501
Number of employees
16,946
Sales / Employee (INR)
10,021,545
Sales / Employee (USD)
104,465
Free-Float
51.04%
Free-Float capitalization (INR)
347,165,269,403
Free-Float capitalization (USD)
3,618,868,255
Average Daily Capital Traded
0.18%
Indicators
Moving average 5 days
2,410.18
Moving average 20 days
2,414.01
Moving average 50 days
2,318.76
Moving average 100 days
2,293.07
Price spread / (MMA5)
+0.14%
Price spread / (MMA20)
+0.30%
Price spread / (MMA50)
-3.65%
Price spread / (MMA100)
-4.72%
STIM
RSI 9 days
40.08
RSI 14 days
47.72
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.14% | -0.51% | +17.64% | +182.14% | 7.09B | |
| +0.18% | -0.26% | +14.57% | +61.74% | 46.36B | |
| +3.03% | -2.01% | +38.07% | +101.71% | 36.94B | |
| +1.96% | +1.03% | +9.24% | +75.52% | 11.52B | |
| +1.33% | +0.17% | -11.79% | +10.89% | 11.44B | |
| +0.96% | +0.57% | +19.32% | +148.82% | 9.17B | |
| -0.47% | +0.16% | +27.34% | +36.96% | 7.27B | |
| +2.60% | +2.01% | +39.80% | -18.32% | 7.06B | |
| +0.61% | -5.43% | -43.52% | +5.23% | 4.92B | |
| -0.09% | -0.34% | +36.98% | +110.43% | 4.57B | |
| Average | +0.98% | -1.54% | +14.76% | +71.51% | 14.63B | |
| Weighted average by Cap. | +1.24% | -2.24% | +19.07% | +74.76% |
Historical Quotes: Glenmark Pharmaceuticals Limited
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
fc0ad20a7cba67d28044c.dL2Imc-7w6lJSX0Dpmrgrx_NkOPVXUvO_0JFEvd6KSE.B_n7tPeMpu16ABJP0w6N6X2pxqaUHAi8uSYgeJAwHk1NhaXbjviazQ4zJA
| Date | Price | Volume | Total |
|---|---|---|---|
| 02:53:28 | 2,406.70 | 303 | 117,724 |
| 02:53:26 | 2,407.00 | 48 | 117,421 |
| 02:53:23 | 2,407.80 | 8 | 117,373 |
| 02:53:04 | 2,407.80 | 3 | 117,365 |
| 02:52:53 | 2,407.00 | 1 | 117,362 |
| 02:52:52 | 2,407.00 | 6 | 117,361 |
| 02:52:48 | 2,407.00 | 1 | 117,355 |
| 02:52:44 | 2,407.90 | 50 | 117,354 |
| 02:52:39 | 2,407.80 | 3 | 117,304 |
| 02:52:38 | 2,408.20 | 493 | 117,301 |
Price Extremes
| 1 week | 2,306.3 |  | 2,431.9 |
| 1 month | 2,222.5 | | 2,537.6 |
| Current year | 1,842 | | 2,537.6 |
| 1 year | 1,792.6 | | 2,537.6 |
| 3 years | 722.1 | | 2,537.6 |
| 5 years | 348.5 | | 2,537.6 |
| 10 years | 161.65 | | 2,537.6 |
Monthly variations
Annual variations
| 2026 | +18.42% | ||
| 2025 | +26.48% | ||
| 2024 | +88.43% | ||
| 2023 | +101.33% | ||
| 2022 | -19.75% | ||
| 2021 | +7.10% | ||
| 2020 | +42.03% | ||
| 2019 | -49.87% | ||
| 2018 | +16.53% | ||
| 2017 | -33.06% | ||
| 2016 | -3.63% | ||
| 2015 | +19.70% | ||
| 2014 | +44.27% | ||
| 2013 | +1.00% | ||
| 2012 | +80.05% | ||
| 2011 | -18.93% | ||
| 2010 | +31.27% | ||
| 2009 | -6.84% | ||
| 2008 | -50.32% | ||
| 2007 | +97.78% | ||
| 2006 | +92.22% | ||
| 2005 | +29.33% | ||
| 2004 | +238.85% | ||
| 2003 | +198.25% | ||
| 2002 | +26.86% | ||
| 2001 | -7.37% | ||
| 2000 | -62.36% |
- Stock Market
- Stocks
- GLENMARK Stock
- Quotes Glenmark Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
